Granules India announced that USFDA has completed an inspection of the facility of Granules Pharmaceuticals, Inc., a wholly-owned foreign subsidiary of the Company located in Chantilly, Virginia, the USA on 22 July 2022 with six (6) observations. Granules Pharmaceuticals, Inc. will respond to these observations within the stipulated time period.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
